'Click' D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity

被引:38
|
作者
Zhang, Jing [2 ]
Zhang, Hai [1 ]
Cai, Wenxian [1 ]
Yu, Leiping [1 ]
Zhen, Xuechu [1 ]
Zhang, Ao [2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Neuropharmacol Lab, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, SOMCL, Shanghai 201203, Peoples R China
基金
美国国家科学基金会;
关键词
Arylbenzazepine; Arylpiperazine; Click reaction; Dopamine receptor; Serotonin 5-HT1A receptor; PARKINSONS-DISEASE; SEROTONIN; LIGANDS; COMPLICATIONS; DOPAMINE-D-2; THERAPEUTICS; DERIVATIVES; THERAPY;
D O I
10.1016/j.bmc.2009.06.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of new 1-aryl-3-benzazepine derivatives containing an arylpiperazinyl function as the N3 substituent were synthesized by combining a D-1 receptor agonistic pharmacophore and a 5-HT1A receptor pharmacophore through Click reaction. Interestingly, these compounds generally do not have good binding affinity at the D-1 receptor, but most compounds are potent at both D-2 and 5-HT1A receptors. Compound 8h, containing 1-m-tolyl-benzazepine scaffold and 2-methoxyphenylpiperazine core, displayed good affinity at all tested receptors, with K-i values of 144, 80, and 133 nM, for the D-1, D-2, and 5-HT1A receptors, respectively. Compound 13 with the triazole moiety formed differently from that in 8h showed the highest affinity at the D-2 receptor with K-i value of 19 nM. This compound also showed moderate affinity at the 5-HT1A (K-i, 105 nM), and D-1 (K-i, 551 nM) receptors. Functional assays indicated that both compounds 13 and 8h are antagonists at D-1 and D-2 receptors, whereas full agonistic activity at the 5-HT1A receptor was observed. In agreement with the binding affinity, compound 13 is a high efficacy D-2 antagonist and 5-HT1A agonist. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4873 / 4880
页数:8
相关论文
共 50 条
  • [1] Recent 5-HT1A receptor agonists
    Gurwitz, D
    DRUG DISCOVERY TODAY, 1999, 4 (03) : 142 - 143
  • [2] Sarizotan hydrochloride -: Antidyskinetic drug 5-HT1A receptor agonist dopamine D2 receptor ligand
    McIntyre, JA
    Castañer, J
    Bayés, M
    DRUGS OF THE FUTURE, 2006, 31 (04) : 314 - 319
  • [3] The multistrategy for design of dopamine D1 and serotonin 5-HT1A receptor ligands
    Zhang, Jing
    Chen, Xuetao
    Zhen, Xuechu
    Zhang, Ao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [4] Investigation of D1 Receptor-Agonist Interactions and D1/D2 Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
    Malo, Marcus
    Brive, Lars
    Luthman, Kristina
    Svensson, Peder
    CHEMMEDCHEM, 2012, 7 (03) : 483 - 494
  • [5] Constitutive activity of a chimeric D2/D1 dopamine receptor
    Kozell, LB
    Neve, KA
    MOLECULAR PHARMACOLOGY, 1997, 52 (06) : 1137 - 1149
  • [6] Effects of 5-HT1A Receptor Stimulation on D1 Receptor Agonist-Induced Striatonigral Activity and Dyskinesia in Hemiparkinsonian Rats
    Dupre, Kristin B.
    Ostock, Corinne Y.
    George, Jessica A.
    Jaunarajs, Karen L. Eskow
    Hueston, Cara M.
    Bishop, Christopher
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (05): : 747 - 760
  • [7] DOPAMINE D1/D2 RECEPTOR INTERACTION
    SASA, M
    AKAIKE, A
    OHNO, Y
    HARA, M
    TAKAORI, S
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1991, 45 (02): : 507 - 510
  • [9] Synthesis and biological activity of a new saccharine derivatives as a dual D2/5-HT1A receptor ligands
    Kulaga, Damian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [10] Interaction of Dopamine D2 and 5-HT1A Receptor Partial Agonism on Antipsychotic Efficacy
    Lloyd, Haydyn
    Deng, Chao
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (02) : 192 - 193